L

Pulmonx Corp
D

LUNG

6.31000
USD
-0.15
(-2.32%)
مغلق
حجم التداول
12,922
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
249,168,516
الأخبار

العنوان: Pulmonx Corp

القطاع: Healthcare
الصناعة: Medical Devices
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.